Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer

This study has been completed.
Information provided by (Responsible Party):
Pfizer Identifier:
First received: November 2, 2007
Last updated: August 6, 2014
Last verified: August 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2014
  Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: November 15, 2011